tel: 0207 132 1440  email:

Dr Philip Woodland BSc MBBS PhD MRCP


I am a Consultant Gastroenterologist and Honorary Senior Lecturer at the Royal London Hospital (Barts Health NHS Trust).


Training and experience

I studied Medicine at University College London Medical. There I also obtained a 1st Class BSc in Pharmacology.

Following my basic medical training on the Barts and The London medical rotation, I trained in gastroenterology at several top London hospitals. My research into gastro-oesophageal reflux disease led to the award of a PhD from Queen Mary University of London and led to the award of a prestigious NIHR Clinical Lectureship at the Royal London Hospital, allowing me to continue my research into oesophageal disorders and to complete training in advanced endoscopic techniques.  Subsequently, I was appointed as a Consultant Gastroenterologist at the Royal London Hospital.


Skills and expertise

I provide investigation, diagnosis and treatment for a wide range of gastrointestinal disorders, including gastro-oesophageal reflux disease (acid reflux), Barrett’s oesophagus, difficulty swallowing and oesophageal motility disorders, irritable bowel syndrome, inflammatory bowel disease (Crohn’s and colitis) and cancers affecting the gastrointestinal tract.

I am skilled in advanced diagnostic and therapeutic endoscopic techniques (including endoscopic ultrasound) and I am a nationally accredited colonoscopist for bowel cancer screening.

I always aim to be friendly and approachable, and I truly believe in making patients feel at ease, giving them the time needed to fully discuss their symptoms and any resulting impact on their lives.


Research Interests

With an active research portfolio at Barts & The London School of Medicine and Dentistry, my research interests include gastro-oesophageal reflux disease and swallowing difficulties. I regularly give talks at international meetings on these subjects and have authored numerous papers and book chapters on gastrointestinal disease.


Memberships and other roles

I am a member of the Royal College of Physicians, the British Society of Gastroenterology, and the American Gastroenterology Association.

I am on the British Society of Gastroenterology Neurogastroenterology Committee.

I am a member of the editorial board for the Neurogastroenterology & Motility Journal.

I peer review research proposals for the Bowel and Cancer Research Grants committee and the National Institute of Health Research.



Woodland P, Batista-Lima F, Lee C, Preston SL, Dettmar P, Sifrim D. Topical protection of human esophageal mucosal integrity. Am J Physiol Gastrointest Liver Physiol 2015; epub ahead of print Apr 23


Woodland P, Aktar R, Mthunzi E, Lee C, Peiris M, Preston SL, Blackshaw LA, Sifrim D. Distinct afferent innervation patterns within the human proximal and distal esophageal mucosa. Am J Physiol Gastrointest Liver Physiol 2015; epub ahead of print Jan 8


Koukias N, Woodland P, Yazaki E, Sifrim D. Supragastric belching: prevalence and association with gastroesophageal reflux disease and esophageal hypomotility. J Neurogastro Motil, In press Apr 2015


Woodland P, Sifrim D. GERD: Body position affects infant GER but not symptoms. Nat Rev Gastroenterol Hepatol 2014; 11: 397-8


Woodland P, Sifrim D. Oesophageal mucosal mucosal barrier: a key factor in the pathophysiology of non-erosive reflux disease (NERD) and a potential target for treatment. Gut 2014; 63: 705-6


Yazaki E, Woodland P, Sifrim D. Uses of esophageal function testing: dysphagia. Gastrointest Endosc Clin N Am 2014; 24: 643-54


Reeves JW, Al-Zinaty M, Woodland P, Sifrim D, Aziz Q, Birch MJ. Sensiprobe - a miniature thermal device incorporating Peltier technology as a diagnostic tool for studying human oesophageal sensitivity. Physiol Meas 2014; 7: 1265-1277


Woodland P, Lee C, Duraisamy Y, Farré R, Dettmar P, Sifrim D. Assessment and protection of esophageal mucosal integrity in patients with heartburn without esophagitis. Am J Gastroenterol. 2013; 108: 535-43


Bravi I*, Woodland P, Gill RS et al. Increased Prandial Air Swallowing and Postprandial Gas-Liquid Reflux Among Patients Refractory to Proton Pump Inhibitor Therapy. Clin Gastroenterol Hepatol 2013; 11: 784-9


Woodland P, Al-Zinaty M, Yazaki E et al. In vivo evaluation of acid-induced changes in oesophageal mucosal integrity and sensitivity in non-erosive reflux disease. Gut 2013; 62: 1256-1261


Woodland P, Sifrim D. Esophageal mucosal integrity in nonerosive reflux disease. J Clin Gastroenterol 2013; 48: 6-12


Woodland P, Sifrim D et al. The neurophysiology of the esophagus. Ann N Y Acad Sci 2013; 1300: 53-70


Woodland P, Amarasinghe G, Sifrim D. Emerging therapeutic options in GERD. Best Pract Res Clin Gastroenterol. 2013; 27: 455-67


Woodland P, Sifrim D. Management of gastroesophageal reflux symptoms that do not respond to proton pump inhibitors. Curr Opin Gastroenterol. 2013; 29: 431-6


Roman S, Woodland P et al. Testing for gastroesophageal reflux in the 21st century. Ann N Y Acad Sci. 2011 Sep;1232(1):358-64


Triadafilopoulos G, Woodland P et al. Barrett's esophagus: proton pump inhibitors and chemoprevention. Ann N Y Acad Sci. 2011 Sep;1232(1):93-113


Woodland P, Sifrim D. The refluxate: The impact of its magnitude, composition and distribution. Best Pract Res Clin Gastroenterol. 2010 Dec;24(6):861-71.


Woodland P, Stubbs B.  Peptic Ulcer Disease. INNOVAIT (Oxford Journals) April 2009




Tel: 020 7132 1440    email:

Post: Professional Medical Management Services, Freepost